Trading Ideas Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 04:35:05 2025-01-21 am EST			5-day change	1st Jan Change
565.45 ^DKK	+2.57%		-5.22%	-10.06%

Jan. 03	New Year, Soft Start
Jan. 03	BNP Paribas Exane Cuts Novo Nordisk PT, Maintains at Outperform	MT

Trading Ideas

NOVO NORDISK A/S: A good level to buy	Nov. 22
NOVO NORDISK A/S: Good timing to anticipate a continuation of the trend	24-09-13
NOVO NORDISK A/S: The underlying trend is to the upside	24-08-15
NOVO NORDISK A/S: Good timing to anticipate a continuation of the trend	24-07-30
NOVO NORDISK A/S: The technical configuration is positive	24-07-18
NOVO NORDISK A/S: There is still some upside potential	24-05-24
NOVO NORDISK A/S: There is still some upside potential	24-05-06
NOVO NORDISK A/S: The technical configuration is positive	24-04-12
NOVO NORDISK A/S: Good timing to anticipate a continuation of the trend	24-03-04
NOVO NORDISK A/S: New upside potential above the resistance level	24-01-04
NOVO NORDISK A/S: The stock is approaching a major resistance level	23-11-24
NOVO NORDISK A/S: The trend should regain control	23-07-18
NOVO NORDISK A/S: There is still some upside potential	23-06-21
NOVO NORDISK A/S: The underlying trend is to the upside	23-02-28
NOVO NORDISK A/S: Technically solid	23-02-03
NOVO NORDISK A/S: The technical configuration is positive	22-11-22
NOVO NORDISK A/S: A long term support level to be taken advantage of	22-10-03
NOVO NORDISK A/S: The technical configuration is positive	22-06-30
NOVO NORDISK A/S: Good timing to anticipate a continuation of the trend	22-03-08
NOVO NORDISK A/S: No turn-around in sight	21-09-16
NOVO NORDISK A/S: A good level to buy	20-12-08
NOVO NORDISK A/S: The underlying trend is in force again	19-07-18
NOVO NORDISK A/S: The underlying trend is to the upside	19-06-25
NOVO NORDISK A/S: A good level to buy	19-04-24
NOVO NORDISK A/S: Attractive timing with a long term view to go long again	18-10-31

Become a member to access more news.

100% Free Registration

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Wegovy, Ozempic Targeted by US for Medicare Price Cuts

January 17, 2025 at 10:36 am EST

Cagrisema sends Novo Nordisk to the mat

December 20, 2024 at 06:20 am EST

NOVO NORDISK : CagriSema results are not worthy of panic

December 20, 2024 at 09:14 am EST